Javier Hererro

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite the promising efficacy of adoptive cell therapies (ACT) in melanoma, complete response rates remain relatively low and outcomes in other cancers are less impressive. The immunosuppressive nature of the tumor microenvironment and the expression of immune-inhibitory ligands, such as PD-L1/CD274 by the tumor and stroma are considered key factors(More)
  • 1